Board logo

subject: Why I Buy Carisoprodol Online [print this page]


Why I Buy Carisoprodol OnlineWhy I Buy Carisoprodol Online

I buy Carisoprodol online pretty regularly, but before I did, I needed to find out the pros and cons of this medication.

Here is some of what I found out.

Why I Buy Carisoprodol Online

Carisoprodol is a centrally-acting skeletal muscle relaxant.

Carisoprodol was developed on the basis of meprobamate (a popular minor tranquilizer that has largely been replaced by the benzodiazepines ), in the hope that it would have better muscle relaxing properties, less potential for abuse, and less risk of overdose than meprobamate.

Carisoprodol a colorless, crystalline powder, having a mild characteristic odor and a bitter taste.

Carisoprodol is slightly soluble in water and freely soluble in alcohol, chloroform and acetone.

The drug's solubility is practically independent of pH.

Side Effects of Carisoprodol

The usual dose of 350 mg is unlikely to engender prominent side effects other than somnolence.

The medication is well tolerated and without adverse effects in the majority of patients for which it is indicated.

In some patients however, and/or early in therapy, Carisoprodol can have the full spectrum of sedative side effects and can impair the patient's ability to operate a firearm, motorcycle, and other machinery of various types especially when taken with medications containing alcohol, in which case an alternative medication would be considered.

The intensity of the side effects of Carisoprodol tends to lessen as therapy continues, as is the case with many other drugs.

Carisoprodol is marketed in the United States under the brand name Soma, and in the United Kingdom and other countries under the brand names Sanoma and Carisoma.

The drug is available by itself or mixed with aspirin and in one preparation (Soma Compound With Codeine) along with codeine and caffeine as well




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)